Klaumwell Research Labs, LLC, U.S., a subsidiary of Italian multinational Medestea Internazionale, announced positive results from a double-blind, placebo-controlled clinical study published in the prestigious, peer-reviewed International Journal of Obesity which demonstrates the efficacy of key ingredients contained in a new appetite control spray. Fullfast™ is a clinically tested dietary supplement that helps reduce excessive feelings of hunger. Containing a proprietary blend of natural botanical extracts, Fullfast™ uses an innovative mouth spray delivery system to facilitate quick ingestion and absorption of its key ingredients. The product is formulated to influence signals in the center of the brain, the hypothalamus, which helps control hunger.
"This product will be welcomed enthusiastically by people who struggle to follow a weight-loss regimen because they feel hungry while dieting," says Eddie Catalfamo, Klaumwell Research Labs President & CEO. "Fullfast™ is easy to use and delivers a pleasant tasting natural mist that helps control hunger."
The key ingredient in Fullfast's patented Hydroxytonin Complex™ is Griffonia Simplicifolia seed extract, which is a natural source of 5-Hydroxytryptophan (5-HTP). 5-HTP is an important precursor to the neurotransmitter serotonin, which is necessary for the body to help regulate mood and control appetite. The other natural botanical extracts found in the formula include gotu kola, dandelion root and artichoke leaf which are all rich in active principles that help with drainage, purification and detoxification. Other ingredients include Guarana extract and Klamath Algae (natural source of phenylethylamine) which may also play a role in regulating appetite. For best results, use as directed five times a day before breakfast, mid-morning, before lunch, mid-afternoon and before dinner.
The findings of the two-month study involving overweight women conducted by scientists at the University of Pavia, Italy, indicate 5HTP-natural extracts may be safely used to reduce hunger and treat the problem of appetite control in a weight loss program. None of the researchers involved in the study have any affiliation with Medestea. The study has been reviewed by Dr. John Fernstrom, Professor of Psychiatry and Pharmacology Research Director - UPMC Weight Management Center, University of Pittsburgh School of Medicine.
Medestea Internazionale S.p.A.